Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19


Infographic: Impact of implant materials and malalignment in unicompartmental knee arthroplasty.

Danese I, Pankaj P, Scott CEH.

Bone Joint Res. 2019 Jul 5;8(6):226-227. doi: 10.1302/2046-3758.86.BJR-2019-0111. eCollection 2019 Jun. No abstract available.


Dual Raltegravir-Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase Inhibitors.

Calza L, Danese I, Magistrelli E, Colangeli V, Manfredi R, Bon I, Re MC, Conti M, Viale P.

HIV Clin Trials. 2016 Feb;17(1):38-47. doi: 10.1080/15284336.2015.1122874. Epub 2016 Jan 5.


Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz.

Calza L, Magistrelli E, Danese I, Colangeli V, Borderi M, Bon I, Re MC, Mancini R, Conti M, Motta R, Viale P.

Curr HIV Res. 2016;14(1):61-70.


Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients.

Calza L, Danese I, Colangeli V, Manfredi R, Magistrelli E, Verucchi G, Conti M, Motta R, Viale P.

Infect Dis (Lond). 2015 Sep;47(9):625-36. doi: 10.3109/23744235.2015.1034169. Epub 2015 Apr 15.


Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: the importance of pre- and posttransplant colonization.

Giannella M, Bartoletti M, Morelli MC, Tedeschi S, Cristini F, Tumietto F, Pasqualini E, Danese I, Campoli C, Lauria ND, Faenza S, Ercolani G, Lewis R, Pinna AD, Viale P.

Am J Transplant. 2015 Jun;15(6):1708-15. doi: 10.1111/ajt.13136. Epub 2015 Mar 4.


Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort study.

Calza L, Danese I, Colangeli V, Vandi G, Manfredi R, Girometti N, Borderi M, Appolloni L, Puggioli C, Viale P.

AIDS Res Hum Retroviruses. 2014 Dec;30(12):1162-9. doi: 10.1089/aid.2014.0113.


Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.

Calza L, Manfredi R, Colangeli V, Trapani FF, Salvadori C, Magistrelli E, Danese I, Verucchi G, Serra C, Viale P.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):547-56. doi: 10.1089/aid.2012.0015. Epub 2012 Oct 25.


FtcR is a new master regulator of the flagellar system of Brucella melitensis 16M with homologs in Rhizobiaceae.

Léonard S, Ferooz J, Haine V, Danese I, Fretin D, Tibor A, de Walque S, De Bolle X, Letesson JJ.

J Bacteriol. 2007 Jan;189(1):131-41. Epub 2006 Oct 20.


The stringent response mediator Rsh is required for Brucella melitensis and Brucella suis virulence, and for expression of the type IV secretion system virB.

Dozot M, Boigegrain RA, Delrue RM, Hallez R, Ouahrani-Bettache S, Danese I, Letesson JJ, De Bolle X, Köhler S.

Cell Microbiol. 2006 Nov;8(11):1791-802. Epub 2006 Jun 27.


A quorum-sensing regulator controls expression of both the type IV secretion system and the flagellar apparatus of Brucella melitensis.

Delrue RM, Deschamps C, Léonard S, Nijskens C, Danese I, Schaus JM, Bonnot S, Ferooz J, Tibor A, De Bolle X, Letesson JJ.

Cell Microbiol. 2005 Aug;7(8):1151-61.


The sheathed flagellum of Brucella melitensis is involved in persistence in a murine model of infection.

Fretin D, Fauconnier A, Köhler S, Halling S, Léonard S, Nijskens C, Ferooz J, Lestrate P, Delrue RM, Danese I, Vandenhaute J, Tibor A, DeBolle X, Letesson JJ.

Cell Microbiol. 2005 May;7(5):687-98.


The Ton system, an ABC transporter, and a universally conserved GTPase are involved in iron utilization by Brucella melitensis 16M.

Danese I, Haine V, Delrue RM, Tibor A, Lestrate P, Stevaux O, Mertens P, Paquet JY, Godfroid J, De Bolle X, Letesson JJ.

Infect Immun. 2004 Oct;72(10):5783-90.


Fun stories about Brucella: the "furtive nasty bug".

Letesson JJ, Lestrate P, Delrue RM, Danese I, Bellefontaine F, Fretin D, Taminiau B, Tibor A, Dricot A, Deschamps C, Haine V, Leonard S, Laurent T, Mertens P, Vandenhaute J, De Bolle X.

Vet Microbiol. 2002 Dec 20;90(1-4):317-28. Review.


Effect of omp10 or omp19 deletion on Brucella abortus outer membrane properties and virulence in mice.

Tibor A, Wansard V, Bielartz V, Delrue RM, Danese I, Michel P, Walravens K, Godfroid J, Letesson JJ.

Infect Immun. 2002 Oct;70(10):5540-6.


Identification of Brucella spp. genes involved in intracellular trafficking.

Delrue RM, Martinez-Lorenzo M, Lestrate P, Danese I, Bielarz V, Mertens P, De Bolle X, Tibor A, Gorvel JP, Letesson JJ.

Cell Microbiol. 2001 Jul;3(7):487-97.


Genetic organisation of the lipopolysaccharide O-antigen biosynthesis region of brucella melitensis 16M (wbk).

Godfroid F, Cloeckaert A, Taminiau B, Danese I, Tibor A, de Bolle X, Mertens P, Letesson JJ.

Res Microbiol. 2000 Oct;151(8):655-68.


Identification and characterization of in vivo attenuated mutants of Brucella melitensis.

Lestrate P, Delrue RM, Danese I, Didembourg C, Taminiau B, Mertens P, De Bolle X, Tibor A, Tang CM, Letesson JJ.

Mol Microbiol. 2000 Nov;38(3):543-51.


Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages.

Godfroid F, Taminiau B, Danese I, Denoel P, Tibor A, Weynants V, Cloeckaert A, Godfroid J, Letesson JJ.

Infect Immun. 1998 Nov;66(11):5485-93.

Supplemental Content

Loading ...
Support Center